Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bioterrorism -- Ignore unavailable to you. Want to Upgrade?

To: Ben Wa who wrote (146)	10/8/2001 11:58:43 PM
From: Biomaven	Read Replies (3) \| Respond to of 891

The current week's Biocentury lists stocks that have received US government funding in the past three years for bioterrorism-related research. Here are the public companies they mention: Diagnostics: ACLA, BDAL, CPHD, CBTE, CRXA, MOT, NGEN, ORCH, TBIO, XTRN. Therapeutics: ABGX, CERS, GILD, GSK, SIGA Vaccines: ACAM, BRL, BREL, MAXY, NVAX. Some of these are clearly not bioterror plays (MOT, GSK). Some I've plain never heard of (XTRN?). It's also not a complete list, as I know that IGEN for one has a CRADA with AMRIID: IGEN International, Inc. (ticker: IGEN, exchange: NASDAQ) News Release - 5/16/2001 IGEN, U.S. Army Sign R&D Agreement on Toxin Tests Collaboration to Include Development of Tests for Seafood Toxins GAITHERSBURG, Md., May 16 /PRNewswire/ -- IGEN International Inc. (Nasdaq: IGEN) and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have entered into a Cooperative Research and Development Agreement (CRADA) to develop tests, based on IGEN's proprietary ORIGEN(R) technology, for food-, water-, and environmentally borne toxins. Under the CRADA, ORIGEN-based assays will be developed for toxins such as ciguatoxin, brevetoxins, botulinum neurotoxins, and staphylococcal enterotoxins. These tests are intended to have application to USAMRIID's role in protecting American troops from diseases caused by biological agents. A commercial objective of the CRADA is to develop products that can be used by government agencies, food processors, and analytical laboratories. One such application of this technology is the potential for detection of toxins in seafood. Peter P.S. I added CPHD to the portfolio of "pure plays."